| Financial Year |
March 31 2023 |
| Monetary Funds |
450,526,996.94 |
| Held-for-trading Financial Assets |
69,083.26 |
| Notes Receivable |
1,257,918.00 |
| Accounts Receivable |
859,050,270.74 |
| Advances to Suppliers |
18,170,018.34 |
| Other Receivables |
163,214,571.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
546,279,189.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,494,782.35 |
| Other Current Assets |
42,765,658.29 |
| Total Current Assets |
2,418,343,101.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
21,922,089.10 |
| Long-term Equity Investment |
65,336,841.53 |
| Investment Properties |
74,350,179.62 |
| Fixed Assetes |
1,363,567,148.31 |
| Under-construction Projects |
451,703,746.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
145,230,864.43 |
| R&D expenses |
-- |
| Goodwill |
15,936,259.91 |
| Long-Term Deferred and Prepaid Expenses |
46,241,248.84 |
| Deferred Income Tax Assets |
77,732,568.17 |
| Other Non-Current Assets |
40,830,475.80 |
| Sub-Total of Non-Current Assets |
2,412,686,371.68 |
| Total Assets |
4,831,029,473.05 |
| Short-Term Loans |
270,242,275.00 |
| Trading Financial liabilities |
1,296,526.57 |
| Notes Payable |
136,686,773.32 |
| Accounts Payable |
854,716,059.22 |
| Accounts Received In Advance |
3,865,900.00 |
| Employee Compensation Payable |
44,321,880.42 |
| Taxes Payable |
29,240,852.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
142,688,536.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
147,872,353.59 |
| Other Current Liabilities |
1,041,058.33 |
| Sub-Total of Current Liabilities |
1,650,527,035.29 |
| Long-term Loans |
641,877,134.76 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,485,482.55 |
| Deferred Income Tax Liabilities |
55,533,336.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
767,635,235.68 |
| Total Liabilities |
2,418,162,270.97 |
| Paid-In Capital(Or Share Stock) |
707,943,506.00 |
| Capital Surplus |
1,179,196,736.46 |
| Surplus Reserve |
70,195,733.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
446,354,073.13 |
| Minority Stockholder's Interest |
1,416,781.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,411,450,420.90 |
| Owner's Equity（Stockholder's Equity） |
2,412,867,202.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,831,029,473.05 |
